Frontiers in Immunology (Jul 2023)
Editorial: CD4+ T cells in HIV: A Friend or a Foe?
- Sakthivel Govindaraj,
- Sakthivel Govindaraj,
- Hemalatha Babu,
- Hemalatha Babu,
- Sunil Kannanganat,
- Monica Vaccari,
- Monica Vaccari,
- Constantinos Petrovas,
- Vijayakumar Velu,
- Vijayakumar Velu
Affiliations
- Sakthivel Govindaraj
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
- Sakthivel Govindaraj
- Division of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, United States
- Hemalatha Babu
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
- Hemalatha Babu
- Division of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, United States
- Sunil Kannanganat
- Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States
- Monica Vaccari
- Division of Immunology, Tulane National Primate Research Center, Covington, LA, United States
- Monica Vaccari
- Department of Microbiology and Immunology, Tulane School of Medicine, New Orleans, LA, United States
- Constantinos Petrovas
- Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland
- Vijayakumar Velu
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
- Vijayakumar Velu
- Division of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, United States
- DOI
- https://doi.org/10.3389/fimmu.2023.1203531
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
